pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 1
ATI-1013
Thromboangiitis obliterans (Buerger disease)
Antidote Therapeutics Inc
0 catalysts
Preclinical
ATI-1701
Tularaemia
Appili Therapeutics Inc
0 catalysts
Preclinical
ATLX–0199
Unspecified Cardiovascular Disorders
Atelerix Life Sciences Inc
0 catalysts
Preclinical
ATORM-S
Xerostomia
← prev
page 60 of 271
next →
131
Pain89
Neurology1
Organoid Science Co Ltd
0 catalysts
ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
ATOVAQUONE AND PROGUANIL HYDROCHLORIDE (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE)
MYLAN
0 catalysts
Phase 2
ATR-04
Skin Rash
$AZTRAzitra, Inc.
0 catalysts
Phase 1
ATR-12
Netherton Syndrome (Bamboo Hair)
$AZTRAzitra, Inc.
0 catalysts
Phase 2
ATRN-119
Ovarian Cancer
$APREAprea Therapeutics, Inc.
0 catalysts
Phase 2
ATSN-101
Leber Congenital Amaurosis (LCA)
Atsena Therapeutics Inc
0 catalysts
Phase 3
ATSN-201
Unspecified Ophthalmological Disorders
Atsena Therapeutics Inc
0 catalysts
Preclinical
ATX-101
T-Cell Lymphomas
Abcon Therapeutics Inc
0 catalysts
Phase 2
ATX-295
Ovarian Cancer
Accent Therapeutics Inc
0 catalysts
Phase 1
AU-409
Bile Duct Cancer (Cholangiocarcinoma)
Auransa Inc
0 catalysts
AUBAGIO
AUBAGIO (TERIFLUNOMIDE)
Sanofi-Aventis US LLC
0 catalysts
Phase 1
AUG-801
Congenital Disorder of Glycosylation
AUG Therapeutics LLC
0 catalysts
AUGMENTIN ES-600
AUGMENTIN ES-600 (AMOXICILLIN AND CLAVULANATE POTASSIUM)
US ANTIBIOTICS
0 catalysts
Preclinical
AUM-302
Neuroblastoma
AUM Biosciences Pte Ltd
0 catalysts
Phase 1
AUR-200
Systemic Lupus Erythematosus
$AUPHAurinia Pharmaceuticals Inc.
0 catalysts
Phase 1
AUT-00201
Myoclonic Seizure
Autifony Therapeutics Ltd
0 catalysts
Phase 1
AUT-00206
Fragile X Syndrome
Autifony Therapeutics Ltd
0 catalysts
Phase 2
AUTO-3
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
$AUTLAutolus Therapeutics plc
0 catalysts
Phase 1
AUTX-703
Myelodysplastic Syndrome (Preleukemia)
Auron Therapeutics Inc
0 catalysts
AUVELITY
AUVELITY (BUPROPION HYDROCHLORIDE)
1 INDICATIONS AND USAGE AUVELITY is indicated for the treatment of major depr…
Sodium-dependent dopamine transporterSodium-dependent noradrenaline transporter
$AXSMAxsome Therapeutics, Inc.
0 catalysts
Phase 2
AV-0328
Streptococcal Pneumonia
Alopexx Inc
0 catalysts
Phase 2
AV-1
Dengue Fever
Glutamate [NMDA] receptor
AbViro LLC
0 catalysts
Phase 2
AV-101
Major Depressive Disorder
Glutamate [NMDA] receptor
$VTGNVistagen Therapeutics, Inc.
0 catalysts
Phase 1
AV-1959D
Alzheimer's Disease
Nuravax Inc
0 catalysts
Phase 1
AV-203
Bladder Cancer
Receptor tyrosine-protein kinase erbB-3
AVEO Pharmaceuticals Inc
0 catalysts
Preclinical
AVA-2206
Cystinuria
Averoa SAS
0 catalysts
Phase 1
AVA-6103
Adenocarcinoma Of The Gastroesophageal Junction
Avacta Life Sciences Ltd
0 catalysts